Skip to main content
. 2022 May 18;14(5):e25102. doi: 10.7759/cureus.25102

Figure 9. Switching between therapies .

Figure 9

*Continue NOAC if INR <2 (half dose if on edoxaban), start VKA (loading dose usually used for phenprocoumon). Continue intensive INR sampling for one month, goal: ≥3 consecutive INR values between 2.0 and 3.0. Edoxaban is not approved in India.

INR: international normalized ratio; NOAC: novel oral anticoagulant; VKA: vitamin K antagonists

The figure is adapted from Steffel et al. (2021; EHRA Practical Guide) [13].